Category: Product Launch
News about product and service launches
New Sample Preparation Solution Simplifies Food Safety Testing
The Thermo Scientific QuEChERS portfolio delivers robust, sensitive quantitation in compliance with global regulatory requirements LANGERWEHE, Germany, Dec. 9, 2021 /PRNewswire/ — Food industry, government and contract testing laboratories performing food safety analysis can now benefit from a new portfolio that offers cost-effective, robust Solid-Phase Extraction (SPE) solutions to support food safety workflows and meet regulatory... Read more
PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance
New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 8, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next... Read more
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more
Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases
TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche’s LightCycler PCR instruments TIB Molbiol will continue to focus on the research and development... Read more
New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing
New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen... Read more
GE Healthcare Announces Three New Alliances to Help Improve Cancer Care
Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care, make precision health more accessible,... Read more
GE Healthcare Names New 3.0T MRI System for Today’s Healthcare Heroes
Chicago, November 28, 2021: GE Healthcare is proud to unveil SIGNA Hero[i], a new 3.0T magnetic resonance imaging (MRI) system named in honor of all the global healthcare workers who continue caring for our global community amidst today’s COVID-19 pandemic. Offering new workflows and AIR Recon DL enhancements, SIGNA Hero is designed to help those... Read more
GE Healthcare Unveils New AI and Digital Technologies and Solutions to Help Solve Healthcare’s Most Pressing Problems
Chicago — November 28, 2021 – At the Radiological Society of North America’s (RSNA) 2021 Annual Meeting, GE Healthcare unveiled around 60 innovative technology solutions spanning the healthcare spectrum including patient screening, diagnostics, therapy planning, guidance, and monitoring. Amidst a global pandemic and mounting pressure on the industry, the company accelerated innovations underpinned by artificial... Read more